Draft Guidance for Industry on Good Importer Practices; Availability, 1692-1693 [E9-453]
Download as PDF
1692
Federal Register / Vol. 74, No. 8 / Tuesday, January 13, 2009 / Notices
Committee Name
Advisory Committee
10-Digit Information
Line Code
Tentative Date of Meeting(s)
Anesthesiology and Respiratory Therapy Devices Panel
February 5, April 30, July 23, September 17, November 12
3014512624
Circulatory System Devices Panel
February 25, May 27, September 24
3014512625
Clinical Chemistry and Clinical Toxicology Devices Panel
March 18–19, June 17–18, October 21–22
3014512514
Dental Products Panel
February 11, May 6, June 17, September 16, December 9
3014512518
Ear, Nose, and Throat Devices Panel
February 24, May 19, August 18, November 17
3014512522
Gastroenterology-Urology Devices Panel
March 20, October 15
3014512523
General and Plastic Surgery Devices Panel
February 26–27, June 9–10, October 15–16
3014512519
General Hospital and Personal Use Devices Panel
March 25–26, July 29–30, October 21–22
3014512520
Hematology and Pathology Devices Panel
April 24, July 17, October 23
3014512515
Immunology Devices Panel
October 15–16
3014512516
Medical Devices Dispute Resolution Panel
Meetings occur as needed
3014510232
Microbiology Devices Panel
February 24–25, September 22–23, October 27–28
3014512517
Molecular and Clinical Genetics Panel
April 15, October 5–6
3014510231
Neurological Devices Panel
February 26–27, May 14–15, September 17–18, December 2–3
3014512513
Obstetrics and Gynecology Devices Panel
February 5–6, May 14–15, August 13–14, November 12–
13
3014512524
Ophthalmic Devices Panel
February 12–13, May 14–15, September 24–25,November
19–20
3014512396
Orthopaedic and Rehabilitation Devices Panel
February 3–4, April 14–15, June 9–10, August 11–12, October 15–16, December 1–2
3014512521
Radiological Devices Panel
February 18, May 12, August 4, November 17
3014512526
National Mammography Quality Assurance Advisory Committee
November 4–5
3014512397
Technical Electronic Product Radiation Safety Standards
Committee
No meeting tentatively scheduled for 2009
3014512399
CENTER FOR FOOD SAFETY AND APPLIED NUTRITION
Food Advisory Committee
May 20–21
3014510564
CENTER FOR VETERINARY MEDICINE
Veterinary Medicine Advisory Committee
April 14
3014512548
NATIONAL CENTER FOR TOXILOGICAL RESEARCH (NCTR)
Science Advisory Board to NCTR
November 17–18
3014512559
Dated: December 24, 2008.
Randall W. Lutter,
Deputy Commissioner for Policy.
[FR Doc. E9–451 Filed 1–12–09; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4160–01–S
[Docket No. FDA–2009–D–0675]
Food and Drug Administration
Draft Guidance for Industry on Good
Importer Practices; Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
VerDate Nov<24>2008
19:10 Jan 12, 2009
Jkt 217001
PO 00000
Notice.
Frm 00031
Fmt 4703
Sfmt 4703
SUMMARY: The Food and Drug
Administration (FDA) is announcing on
behalf of several members of the
Interagency Working Group on Import
Safety (agencies) the availability of a
draft guidance for industry entitled
‘‘Good Importer Practices.’’ This draft
guidance document provides general
recommendations to importers on
possible practices and procedures they
may follow to increase the likelihood
the products they import are in
E:\FR\FM\13JAN1.SGM
13JAN1
Federal Register / Vol. 74, No. 8 / Tuesday, January 13, 2009 / Notices
compliance with applicable U.S. safety
and security requirements. The
recommendations provided here are
intended to promote and facilitate an
assessment by importers of a product’s
life cycle so the importer may make
sound decisions about how best to
address the product’s potential to cause
harm and to facilitate compliance with
U.S. requirements.
DATES: Although you can comment on
any guidance at any time (see 21 CFR
10.115(g)(5)), to ensure that the agencies
consider your comments on this draft
guidance before they begin work on the
final version of the guidance, submit
written or electronic comments on the
draft guidance by April 13, 2009.
ADDRESSES: Submit written requests for
single copies of the draft guidance to the
Food and Drug Administration, Office of
Policy and Planning, 10903 New
Hampshire Ave., White Oak Building 1,
4th Floor,Silver Spring, MD 20993.
Send one self-addressed adhesive label
to assist the office in processing your
request.Submit written comments on
the draft guidance to the Division of
Dockets Management (HFA–305), Food
and Drug Administration, 5630 Fishers
Lane, rm. 1061, Rockville, MD 20852.
Submit electronic comments to https://
www.regulations.gov. All comments
should be identified with the docket
number found in brackets in the
heading of this document. See the
SUPPLEMENTARY INFORMATION section for
electronic access to the draft guidance
document.
FOR FURTHER INFORMATION CONTACT:
Jeffrey Shuren, Food and Drug
Administration, 10903 New Hampshire
Avenue, White Oak Building 1, Silver
Spring, MD 20993, 301–796–4840.
SUPPLEMENTARY INFORMATION:
I. Background
FDA is announcing on behalf of the
agencies1 the availability of a draft
guidance for industry entitled ‘‘Good
Importer Practices.’’ This draft guidance
is issued in response to
recommendations contained in the
Action Plan for Import Safety: A
Roadmap for Continual Improvement
(Action Plan) issued on November 6,
2007, by the Interagency Working Group
on Import Safety (Working Group)
established by Executive Order 13439
1 The agencies who developed this draft guidance
are the U.S. Consumer Product Safety Commission,
the Department of Agriculture, the Department of
Commerce, the Department of Health and Human
Services (FDA), the Department of Homeland
Security, the Department of Transportation, and the
Environmental Protection Agency, as well as with
input from the Office of the U.S. Trade
Representative.
VerDate Nov<24>2008
19:10 Jan 12, 2009
Jkt 217001
(see https://www.importsafety.gov/
report/actionplan.pdf). The Action Plan
recommends that the Federal
Government work with the importing
community and other members of the
public to develop Good Importer
Practices and issue guidance. The
Action Plan specifies that the focus of
these practices should be to ensure that
imported products meet U.S. standards,
as well as to promote effective supplychain management. The Action Plan
recommended that these practices be
risk-based and provide concrete
guidance to the importing community
for evaluating imported products. This
evaluation would be based on due
diligence and preventive control
principles.
This guidance is intended for use by
the importer that initiates or causes the
entry or attempted entry of foreignsourced products into the United States
or the reimportation of U.S.-made
products (American goods returned) for
commercial purposes to help ensure
that such products are safe and comply
with applicable U.S. requirements.2 At
any point during the product’s life
cycle, hazards can be introduced that
may place consumers at risk unless
appropriate preventive controls are
implemented. In general, the
recommendations advise the importer to
know the foreign firms with whom they
do business and through which the
products they purchase pass,
understand the products they import
and their vulnerabilities, understand the
hazards that may be introduced during
the product life cycle, and ensure that
these hazards have been properly
controlled and monitored. Importers
should consider instituting practices to
identify and minimize risk. Importers
should put into place controls for
known vulnerabilities, such as to
microbiological contamination or
product defects, and monitor for other
risks, such as counterfeiting or
intentional contamination.
These Good Importer Practices are
broadly organized by four guiding
principles. These four guiding
principles are as follows:
• Establishing a product safety
management program
• Knowing the product and
applicable U.S. requirements
• Verifying product and firm
compliance with U.S. requirements
throughout the supply chain and
While this guidance document sets out
principles and recommendations for helping to
ensure the safety and security of imported products,
the principles and the non-customs related
recommendations are also applicable to helping
ensure the safety and security of products that are
domestically produced.
2
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
1693
product life cycle
• Taking corrective and preventive
action when the imported product
or firm is not compliant with U.S.
Requirements
The guidance suggests actions the
importer can take to accomplish each of
these objectives.
This draft guidance is being issued
consistent with the Office of
Management and Budget’s Final
Bulletin for Agency Good Guidance
Practices (No. 07–02 (M–07–07)). The
draft guidance, when finalized, will
represent the agencies’ current thinking
on Good Importer Practices. It does not
create or confer any rights for or on any
person and does not operate to bind the
agencies or the public. An alternative
approach may be used if such approach
satisfies the requirements of the
applicable U.S. statutes and regulations.
II. Comments
FDA is coordinating the receipt of
submitted comments on behalf of the
agencies. Interested persons may submit
to FDA’s Division of Dockets
Management (see ADDRESSES) written or
electronic comments regarding this
document. Submit a single copy of
electronic comments or two paper
copies of any mailed comments, except
that individuals may submit one paper
copy. Comments are to be identified
with the docket number found in
brackets in the heading of this
document. Received comments may be
seen in the Division of Dockets
Management between 9 a.m. and 4 p.m.,
Monday through Friday.
Please note that on January 15, 2008,
the FDA Division of Dockets
Management Web site transitioned to
the Federal Dockets Management
System (FDMS). FDMS is a
Government-wide, electronic docket
management system. Electronic
comments or submissions will be
accepted by FDA only through FDMS at
https://www.regulations.gov.
III. Electronic Access
Persons with access to the Internet
may obtain the document at either
https://www.fda.gov/oc/guidance/
goodimportpractice.html or https://
www.regulations.gov.
Dated: January 8, 2009.
Jeffrey Shuren,
Associate Commissioner for Policy and
Planning.
[FR Doc. E9–453 Filed 1–12–09; 8:45 am]
BILLING CODE 4160–01–S
E:\FR\FM\13JAN1.SGM
13JAN1
Agencies
[Federal Register Volume 74, Number 8 (Tuesday, January 13, 2009)]
[Notices]
[Pages 1692-1693]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-453]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2009-D-0675]
Draft Guidance for Industry on Good Importer Practices;
Availability
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing on behalf
of several members of the Interagency Working Group on Import Safety
(agencies) the availability of a draft guidance for industry entitled
``Good Importer Practices.'' This draft guidance document provides
general recommendations to importers on possible practices and
procedures they may follow to increase the likelihood the products they
import are in
[[Page 1693]]
compliance with applicable U.S. safety and security requirements. The
recommendations provided here are intended to promote and facilitate an
assessment by importers of a product's life cycle so the importer may
make sound decisions about how best to address the product's potential
to cause harm and to facilitate compliance with U.S. requirements.
DATES: Although you can comment on any guidance at any time (see 21 CFR
10.115(g)(5)), to ensure that the agencies consider your comments on
this draft guidance before they begin work on the final version of the
guidance, submit written or electronic comments on the draft guidance
by April 13, 2009.
ADDRESSES: Submit written requests for single copies of the draft
guidance to the Food and Drug Administration, Office of Policy and
Planning, 10903 New Hampshire Ave., White Oak Building 1, 4th
Floor,Silver Spring, MD 20993. Send one self-addressed adhesive label
to assist the office in processing your request.Submit written comments
on the draft guidance to the Division of Dockets Management (HFA-305),
Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville,
MD 20852. Submit electronic comments to https://www.regulations.gov. All
comments should be identified with the docket number found in brackets
in the heading of this document. See the SUPPLEMENTARY INFORMATION
section for electronic access to the draft guidance document.
FOR FURTHER INFORMATION CONTACT: Jeffrey Shuren, Food and Drug
Administration, 10903 New Hampshire Avenue, White Oak Building 1,
Silver Spring, MD 20993, 301-796-4840.
SUPPLEMENTARY INFORMATION:
I. Background
FDA is announcing on behalf of the agencies\1\ the availability of
a draft guidance for industry entitled ``Good Importer Practices.''
This draft guidance is issued in response to recommendations contained
in the Action Plan for Import Safety: A Roadmap for Continual
Improvement (Action Plan) issued on November 6, 2007, by the
Interagency Working Group on Import Safety (Working Group) established
by Executive Order 13439 (see https://www.importsafety.gov/report/
actionplan.pdf). The Action Plan recommends that the Federal Government
work with the importing community and other members of the public to
develop Good Importer Practices and issue guidance. The Action Plan
specifies that the focus of these practices should be to ensure that
imported products meet U.S. standards, as well as to promote effective
supply-chain management. The Action Plan recommended that these
practices be risk-based and provide concrete guidance to the importing
community for evaluating imported products. This evaluation would be
based on due diligence and preventive control principles.
---------------------------------------------------------------------------
\1\ The agencies who developed this draft guidance are the U.S.
Consumer Product Safety Commission, the Department of Agriculture,
the Department of Commerce, the Department of Health and Human
Services (FDA), the Department of Homeland Security, the Department
of Transportation, and the Environmental Protection Agency, as well
as with input from the Office of the U.S. Trade Representative.
---------------------------------------------------------------------------
This guidance is intended for use by the importer that initiates or
causes the entry or attempted entry of foreign-sourced products into
the United States or the reimportation of U.S.-made products (American
goods returned) for commercial purposes to help ensure that such
products are safe and comply with applicable U.S. requirements.\2\ At
any point during the product's life cycle, hazards can be introduced
that may place consumers at risk unless appropriate preventive controls
are implemented. In general, the recommendations advise the importer to
know the foreign firms with whom they do business and through which the
products they purchase pass, understand the products they import and
their vulnerabilities, understand the hazards that may be introduced
during the product life cycle, and ensure that these hazards have been
properly controlled and monitored. Importers should consider
instituting practices to identify and minimize risk. Importers should
put into place controls for known vulnerabilities, such as to
microbiological contamination or product defects, and monitor for other
risks, such as counterfeiting or intentional contamination.
---------------------------------------------------------------------------
\2\ While this guidance document sets out principles and
recommendations for helping to ensure the safety and security of
imported products, the principles and the non-customs related
recommendations are also applicable to helping ensure the safety and
security of products that are domestically produced.
---------------------------------------------------------------------------
These Good Importer Practices are broadly organized by four guiding
principles. These four guiding principles are as follows:
Establishing a product safety management program
Knowing the product and applicable U.S. requirements
Verifying product and firm compliance with U.S.
requirements throughout the supply chain and product life cycle
Taking corrective and preventive action when the imported
product or firm is not compliant with U.S. Requirements
The guidance suggests actions the importer can take to accomplish each
of these objectives.
This draft guidance is being issued consistent with the Office of
Management and Budget's Final Bulletin for Agency Good Guidance
Practices (No. 07-02 (M-07-07)). The draft guidance, when finalized,
will represent the agencies' current thinking on Good Importer
Practices. It does not create or confer any rights for or on any person
and does not operate to bind the agencies or the public. An alternative
approach may be used if such approach satisfies the requirements of the
applicable U.S. statutes and regulations.
II. Comments
FDA is coordinating the receipt of submitted comments on behalf of
the agencies. Interested persons may submit to FDA's Division of
Dockets Management (see ADDRESSES) written or electronic comments
regarding this document. Submit a single copy of electronic comments or
two paper copies of any mailed comments, except that individuals may
submit one paper copy. Comments are to be identified with the docket
number found in brackets in the heading of this document. Received
comments may be seen in the Division of Dockets Management between 9
a.m. and 4 p.m., Monday through Friday.
Please note that on January 15, 2008, the FDA Division of Dockets
Management Web site transitioned to the Federal Dockets Management
System (FDMS). FDMS is a Government-wide, electronic docket management
system. Electronic comments or submissions will be accepted by FDA only
through FDMS at https://www.regulations.gov.
III. Electronic Access
Persons with access to the Internet may obtain the document at
either https://www.fda.gov/oc/guidance/goodimportpractice.html or http:/
/www.regulations.gov.
Dated: January 8, 2009.
Jeffrey Shuren,
Associate Commissioner for Policy and Planning.
[FR Doc. E9-453 Filed 1-12-09; 8:45 am]
BILLING CODE 4160-01-S